Opticyte, Inc.
Opticyte is a medical device company dedicated to transforming the standard of care for hemorrhage, sepsis, and other leading causes of organ failure. Their mission is to save lives through early detection and real-time measurement of cellular and blood oxygen levels, providing accurate diagnostics for all skin tones and addressing critical health equity issues. Founded in 2016 as a spinout from the University of Washington, Opticyte is pioneering the first device to measure oxygen inside cells in real time, aiming to reduce organ failure and death associated with hemorrhage, sepsis, and other critical illnesses. The company is recognized for its innovative approach, commitment to health equity, and strong leadership in medical technology.
Opticyte, Inc.
4000 Mason Road, Suite 300 Seattle, WA 98195
Opticyte, Inc. is currently seeking investment
Opticyte, Inc. is seeking a seed investment in the range of less-than-1m
What We Do
The Opticyte VitalO₂ is the first device to monitor both cellular oxygen and blood oxygen saturation (pulse oximetry) in real time. It provides comprehensive, unbiased data for early detection of oxygen deficiency, enabling clinicians to diagnose, treat, and track patient responses more effectively. The device is engineered for use in emergency departments, intensive care units, and operating rooms, and is designed to provide accurate readings for all skin tones.
Diagnostics
Digital Health Technologies
Show More (1)Services
FDA Regulated Medical Devices
Battlefield Resuscitation
Key People
News & Updates
The Opticyte VitalO₂ received Breakthrough Device Designation from the US FDA for its potential to provide more effective treatment over the existing standard of care for identifying and treating life-threatening organ dysfunction.
Recognized by Inc. Media Magazine as a top 10 medical device innovator in 2025.
Opticyte was selected as a finalist for the MedTech Innovator Award in 2023.
Opticyte was selected for the MedTech Accelerator 2023 cohort, recognizing its innovation and growth potential.
Opticyte was featured in Inc. Media Magazine as a top 10 medical device innovator.
Opticyte's technology and mission were highlighted in an NIH article.